Lack of Efficacy of MVA85A TB Vaccine Candidate:Potential Outcomes

It is disturbing to see the leading vaccine candidate against tuberculosis (TB) shows a near total lack of efficacy in the recently concluded phase 2b trial in Cape Town, South Africa. The implications of these results are many and enormous - some of them are enlightening and will give us constructive future evidence towards conduct of similar exercises.